Difference between revisions of "Brio™ Rechargeable IPG"
Jump to navigation
Jump to search
(a correction) |
(Main characteristics) |
||
| Line 47: | Line 47: | ||
== Main characteristics == | == Main characteristics == | ||
<!-- This section should describe the technology in more detail. Here should be information about the used hardware and software, available features, chemical composition and so on, provided that they are available. Second half of this section should offer information on history of the technology. When it was created, unveiled, developed, announced to the public or when it was available to purchase. Anything related to the technology that can be pinpointed to a certain date should be in this section together with relevant commentary.--> | <!-- This section should describe the technology in more detail. Here should be information about the used hardware and software, available features, chemical composition and so on, provided that they are available. Second half of this section should offer information on history of the technology. When it was created, unveiled, developed, announced to the public or when it was available to purchase. Anything related to the technology that can be pinpointed to a certain date should be in this section together with relevant commentary.--> | ||
| − | + | "DBS systems operate open-loop"<ref>PICILLO, Marina, FASANO, Alfonso. Recent advances in Essential Tremor: Surgical treatment. Parkinsonism & Related Disorders, 2016, 22(1), S171–S175. DOI: 10.1016/j.parkreldis.2015.09.012 Available online at: http://www.sciencedirect.com/science/article/pii/S1353802015003879 (Retrieved 6th April, 2017).</ref> | |
=== Purpose === | === Purpose === | ||
<!-- This is a very short description of the technology's purpose. What will it be doing, for what goal was it created, how it modifies human cognition. Keep this as brief as possible. --> | <!-- This is a very short description of the technology's purpose. What will it be doing, for what goal was it created, how it modifies human cognition. Keep this as brief as possible. --> | ||
Revision as of 11:18, 6 April 2017
| Brio™ Rechargeable IPG | |
|---|---|
|
|
| Category | Deep brain stimulation |
| Developer | St. Jude Medical [1] |
| Announced | 2009 [1] |
| Released | Developers:
Consumers: 2009 [1] |
| Price | 19,150 USD [2] |
| Max output | 12.512.5 T 12.5 mA 0.0125 A [3] |
| Session duration | 0.050.05 s 8.333334e-4 minute [4] |
| Scalp location | subthalamic nucleus, globus pallidus internus [5][6] |
| Weight | 29 g [1] |
| Controls |
Brio™ Patient Programmer [7] |
| Data available | |
| Risk factor | |
| Medical prescription | |
| https://www.sjmglobal.com/en-int/professionals/featured-products/neuromodulation/deep-brain-stimulation/implantable-pulse-generators/brio-ipg | |
http://www.medicalnewstoday.com/articles/295376.php?trendmd-shared=0
http://www.businesswire.com/news/home/20090909005095/en/St.-Jude-Medical-Receives-CE-Mark-Approval
Contents
Main characteristics
"DBS systems operate open-loop"[8]
Purpose
Company & People
Important Dates
Enhancement/Therapy/Treatment
Ethical & Health Issues
http://onlinelibrary.wiley.com/doi/10.1111/ner.12026/full
Public & Media Impact and Presentation
Public Policy
Related Technologies, Projects or Scientific Research
References
- ↑ 1.0 1.1 1.2 1.3 St. Jude Medical. St. Jude Medical Receives CE Mark Approval for World’s Smallest, Longest-Lasting Rechargeable Deep Brain Stimulator for Parkinson’s Disease. Newswise, Inc [online]. 2009, Sep 9. Available online at: http://www.newswise.com/articles/st-jude-medical-receives-ce-mark-approval-for-world-s-smallest-longest-lasting-rechargeable-deep-brain-stimulator-for-parkinson-s-disease-first-patient-implanted-with-brio-neurostimulator-at-university-of-cologne-germany32 (Retrieved 6th April, 2017).
- ↑ Australian Government. Private Health Insurance (Prostheses) Rules 2015 (No. 1). Federal Register of Legislation [online]. Available online at: https://www.legislation.gov.au/Details/F2015C00649/Html/Volume_2 (Retrieved 6th April, 2017).
- ↑ TODO
- ↑ TODO
- ↑ OKUN, M. et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. The Lancet Neurology, 2012, 11(2), 140-149. Available online at: http://www.sciencedirect.com/science/article/pii/S1474442211703088 (Retrieved 6th April, 2017).
- ↑ PREDA, F. et al. Switching from constant voltage to constant current in deep brain stimulation: a multicenter experience of mixed implants for movement disorders. European Journal of Neurology, 2016, 23(1), 190–195. Doi:10.1111/ene.12835 Available online at: http://onlinelibrary.wiley.com/doi/10.1111/ene.12835/full (Retrieved 6th April, 2017).
- ↑ St. Jude Medical. Brio™ Patient Programmer. U.S. Food and Drug Administration [online]. Available online at: www.accessdata.fda.gov/cdrh_docs/pdf14/P140009c.pdf (Retrieved 6th April, 2017).
- ↑ PICILLO, Marina, FASANO, Alfonso. Recent advances in Essential Tremor: Surgical treatment. Parkinsonism & Related Disorders, 2016, 22(1), S171–S175. DOI: 10.1016/j.parkreldis.2015.09.012 Available online at: http://www.sciencedirect.com/science/article/pii/S1353802015003879 (Retrieved 6th April, 2017).
